Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Other Working Capital Changes (2022 - 2025)

Corvus Pharmaceuticals has reported Other Working Capital Changes over the past 4 years, most recently at $204000.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $204000.0 for Q4 2025, down 82.53% from a year ago — trailing twelve months through Dec 2025 was -$941000.0 (down 159.29% YoY), and the annual figure for FY2025 was -$941000.0, down 159.29%.
  • Other Working Capital Changes for Q4 2025 was $204000.0 at Corvus Pharmaceuticals, up from -$64000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for CRVS hit a ceiling of $1.2 million in Q4 2024 and a floor of -$1.1 million in Q2 2025.
  • Median Other Working Capital Changes over the past 4 years was -$33500.0 (2025), compared with a mean of -$24500.0.
  • Biggest five-year swings in Other Working Capital Changes: surged 2333.33% in 2024 and later plummeted 303.4% in 2025.
  • Corvus Pharmaceuticals' Other Working Capital Changes stood at -$844000.0 in 2022, then surged by 105.69% to $48000.0 in 2023, then surged by 2333.33% to $1.2 million in 2024, then plummeted by 82.53% to $204000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were $204000.0 (Q4 2025), -$64000.0 (Q3 2025), and -$1.1 million (Q2 2025) per Business Quant data.